医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Savonix and Tucker Medical Announce Partnership to Establish Digital Cognitive Assessment as Standard Routine Care in Singapore

2018年10月16日 PM09:30
このエントリーをはてなブックマークに追加


 

SINGAPORE

Savonix, a global leader in digital tests for cognitive health, and Tucker Medical, a multi-specialty practice offering personalized medicine and care in medical oncology, gastroenterology, and family medicine, today announced a partnership to provide access to the Savonix Cognitive Assessment platform as part of its clinical offerings.

This partnership is built on a shared understanding that each patient is unique and should be treated based on their individual health needs, with the ultimate goal and vision to help improve preventive care and oncology treatment in Singapore. Tucker Medical, with its Personalized Medicine services, conducts baseline screenings across multiple areas of a person’s health. The Savonix Cognitive Assessment platform will be used to generate a baseline and ongoing assessment across a broad spectrum of cognitive function, including working memory, attention, executive function, and processing speed.

“We are excited to bring affordable and efficient cognitive testing to Singapore and are pleased to partner with the team at Tucker Medical who share our belief that cognitive health plays a vital role in overall health,” said Dr. Mylea Charvat, CEO and Founder of Savonix. “Savonix will be a great asset to Tucker Medical’s oncology program. During and after chemotherapy treatment, it is common for patients to experience ‘chemo-fog’, a type of mental cloudiness that impairs memory and concentration. Savonix can be used to track cognition and provide insights for intervention and personalized approaches to care.”

Dr. Steven Tucker, CEO of Tucker Medical added: “We are excited to work with Savonix to integrate cognitive health into our routine medical assessment. Since we are a multi-specialty practice, defining, improving and maintaining cognitive health adds clear value to our patients, whether they are seeing us for treatment of disease or general primary care. We believe in tracking all aspects of health and the Savonix platform creates clear and reproducible measurements for baseline and ongoing assessments. Chronic diseases, from diabetes to cancer, can impact cognition, and now we can measure and act on this dimension of health.”

About Tucker Medical

Tucker Medical Pte Ltd, is a Singapore-based multi-specialty medical practice that provides both general primary care and sub-specialty services. Founded in 2011, Tucker Medical now offers integrated care in oncology, gastroenterology, hepatology, family medicine, nutrition, and mental health services in Singapore and to patients across Southeast Asia. To learn more about Tucker Medical, visit tuckermedical.com.

About Savonix

Savonix delivers a fully mobile assessment of cognitive function available on Android and iOS for phone and tablet, the Savonix Cognitive Assessment platform is an accurate, accessible and affordable tool for professional cognitive screens. It empowers healthcare providers, payers and researchers to evaluate and leverage results to improve health and treatment outcomes. Led by clinical neuropsychologists and digital health technology experts, the company has established itself as an authority on cognition globally. To learn more about Savonix, visit Savonix.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20181016005404/en/

CONTACT

Savonix
Kimberly Ha
KKH Advisors
kimberly.ha@kkhadvisors.com
917-291-5744
or
Tucker
Medical
Veronica Ku
vku@tuckermedical.com

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • 武田薬品、シャイアー買収提案に関する臨時株主総会通知案内状の発行を発表
  • China National Medical Products Administration (NMPA) Approves Gilead’s Vemlidy® (Tenofovir Alafenamide) for Chronic Hepatitis B Virus (HBV) Infection
  • Celltrion Healthcare: Biosimilars Have the Potential to Deliver Dramatic Cost Savings for US and European Healthcare Systems
  • 中国のNo.1ハイテク・フェアCHTF 2018のハイライト
  • Stanford Neuroscientist Karl Deisseroth Receives Japan’s Kyoto Prize in Advanced Technology